Showing 1,277 results

Filters Content type: News, Editors' picks, About HIV Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

New & experimental HIV treatments

TAG/i-base 2012 Pipeline Report - HIV/HCV/TB

Editor's pick
Treatment Action Group
21 July 2012
New & experimental HIV treatments

HIV drug reduces graft-vs.-host disease in bone marrow transplant patients

Editor's pick
Google Alerts HIV
12 July 2012
New & experimental HIV treatments

Shionogi-ViiV Healthcare announces positive initial data from phase III study of dolutegravir-based regimen vs Atripla in HIV

Editor's pick
Market Watch (press release)
11 July 2012
New & experimental HIV treatments

HIV quad pill 'may improve care'

Editor's pick
BBB News
29 June 2012
New & experimental HIV treatments

Gilead Sciences files for approval of cobicistat

Editor's pick
Bloomberg BusinessWeek
29 June 2012
The search for a cure

Four-class, five-drug regimen given to monkeys shows signs of producing long-term viral load reductions off treatment

News
29 June 2012
PrEP science

The road to PrEP: trials, regulation and roll-out

News
25 June 2012
Weight gain & lipodystrophy

Theratechnologies sinks on HIV drug setback

Editor's pick
Reuters
22 June 2012
New & experimental HIV treatments

European Medicines Agency Validates Gilead ’s Marketing Application for Elvitegravir for Treatment of HIV Infection

Editor's pick
Gilead press release
19 June 2012
New & experimental HIV treatments

New Drug-Screening Method Yields Long-Sought Anti-HIV Compounds

Editor's pick
Scripps Research Institute
15 June 2012
Undetectable viral load & treatment as prevention

Study shows that use of darunavir/ritonavir and etravirine in HIV treatment as a prevention method is biologically plausible

News
13 June 2012
New & experimental HIV treatments

UBC drug formulation receives $1.1 million for clinical development as HIV treatment

Editor's pick
EurekAlert (press release)
6 June 2012
New & experimental HIV treatments

Gilead Files European Marketing Application for Boosting Agent Cobicistat

Editor's pick
Gilead press release
25 May 2012
Drug interactions & pharmacokinetics

13th International workshop on Clinical Pharmacology of HIV Therapy 16–18 April 2012, Barcelona

Editor's pick
i-base
23 May 2012
New & experimental HIV treatments

Broad-Spectrum Antivirals: The Future of HIV Treatment?

Editor's pick
The Body
17 May 2012
New & experimental HIV treatments

FDA Panel Endorses 'Quad' Pill for HIV

Editor's pick
MedPage Today HIV/AIDS
14 May 2012
New & experimental HIV treatments

Gilead’s Quad Pill Raises Kidney Questions, FDA Says

Editor's pick
Bloomberg Business Week
9 May 2012
The search for a cure

Study using stem cell therapy shows promise in fight against HIV

Editor's pick
Eurekalert Inf Dis
3 May 2012
New & experimental hepatitis C treatment

No Relevant Interactions Between Telaprevir and Two Newest Nonnucleosides Rilpivirine & Etravirine

Editor's pick
NATAP
20 April 2012
New & experimental HIV treatments

Cobicistat Doubles to Triples Exposure of GS-7340 (a Tenofovir Prodrug) and Resulting Tenofovir

Editor's pick
NATAP
20 April 2012
Government, leadership & policy

Three Big HIV Days in May at the FDA

Editor's pick
AIDSMeds
19 April 2012
New & experimental HIV treatments

DFH Pharma to Collaborate with National Institutes of Health to Develop 2nd Generation HIV Maturation Inhibitor Drugs

Editor's pick
PR Newswire
16 April 2012
Side effects

CROI: Crofelemer Reduces Diarrhea in People with HIV; FDA Grants Priority Review

Editor's pick
HIVandHepatitis.com
13 April 2012
The search for a cure

Engineering CD8 Cells to Kill HIV in Tissues

Editor's pick
AIDSMeds
13 April 2012